世界の医薬品産業ガイド

Abstract

Datamonitor' s Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

• Contains an executive summary and data on value, volume and segmentation
• Provides textual analysis of the industry' s prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
• Includes a five-year forecast of the industry

Highlights

The global pharmaceuticals market grew by 5.5% in 2007 to reach a value of $577.2 billion.

In 2012, the market is forecast to have a value of $737.9 billion, an increase of 27.8% since 2007.

Sales of cardiovascular therapies account for 19.5% of the market by value.

The Americas is the largest pharmaceuticals market, accounting for 55% of the global market' s value.

Pfizer is the leading company in the market, holding an 8.1% market share by value.

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Table of Contents

CHAPTER 1 Introduction

• 1.1 What is this report about?
• 1.2 Who is the target reader?
• 1.3 How to use this report
• 1.4 Definitions

CHAPTER 2 Global Pharmaceuticals

• 2.1 Market Overview
• 2.2 Market Value
• 2.3 Market Segmentation I
• 2.4 Market Segmentation II
• 2.5 Market Share
• 2.6 Five Forces Analysis
• 2.7 Market Forecasts

CHAPTER 3 Pharmaceuticals in Canada

• 3.1 Market Overview
• 3.2 Market Value
• 3.3 Market Segmentation I
• 3.4 Market Segmentation II
• 3.5 Market Share
• 3.6 Five Forces Analysis
• 3.7 Market Forecasts
• 3.8 Macroeconomic Indicators

CHAPTER 4 Pharmaceuticals in the United States

• 4.1 Market Overview
• 4.2 Market Value
• 4.3 Market Segmentation I
• 4.4 Market Segmentation II
• 4.5 Market Share
• 4.6 Five Forces Analysis
• 4.7 Market Forecasts
• 4.8 Macroeconomic Indicators

CHAPTER 5 Pharmaceuticals in China

• 5.1 Market Overview
• 5.2 Market Value
• 5.3 Market Segmentation I
• 5.4 Market Segmentation II
• 5.5 Market Share
• 5.6 Five Forces Analysis
• 5.7 Market Forecasts
• 5.8 Macroeconomic Indicators

CHAPTER 6 Pharmaceuticals in Japan

• 6.1 Market Overview
• 6.2 Market Value
• 6.3 Market Segmentation I
• 6.4 Market Segmentation II
• 6.5 Market Share
• 6.6 Five Forces Analysis
• 6.7 Market Forecasts
• 6.8 Macroeconomic Indicators

CHAPTER 7 Pharmaceuticals in Belgium

• 7.1 Market Overview
• 7.2 Market Value
• 7.3 Market Segmentation I
• 7.4 Market Segmentation II
• 7.5 Market Share
• 7.6 Five Forces Analysis
• 7.7 Market Forecasts
• 7.8 Macroeconomic Indicators

CHAPTER 8 Pharmaceuticals in France

• 8.1 Market Overview
• 8.2 Market Value
• 8.3 Market Segmentation I
• 8.4 Market Segmentation II
• 8.5 Market Share
• 8.6 Five Forces Analysis
• 8.7 Market Forecasts
• 8.8 Macroeconomic Indicators

CHAPTER 9 Pharmaceuticals in Germany

• 9.1 Market Overview
• 9.2 Market Value
• 9.3 Market Segmentation I
• 9.4 Market Segmentation II
• 9.5 Market Share
• 9.6 Five Forces Analysis
• 9.7 Market Forecasts
• 9.8 Macroeconomic Indicators

CHAPTER 10 Pharmaceuticals in Italy

• 10.1 Market Overview
• 10.2 Market Value
• 10.3 Market Segmentation I
• 10.4 Market Segmentation II
• 10.5 Market Share
• 10.6 Five Forces Analysis
• 10.7 Market Forecasts
• 10.8 Macroeconomic Indicators

CHAPTER 11 Pharmaceuticals in the Netherlands

• 11.1 Market Overview
• 11.2 Market Value
• 11.3 Market Segmentation I
• 11.4 Market Segmentation II
• 11.5 Market Share
• 11.6 Five Forces Analysis
• 11.7 Market Forecasts
• 11.8 Macroeconomic Indicators

CHAPTER 12 Pharmaceuticals in Spain

• 12.1 Market Overview
• 12.2 Market Value
• 12.3 Market Segmentation I
• 12.4 Market Segmentation II
• 12.5 Market Share
• 12.6 Five Forces Analysis
• 12.7 Market Forecasts
• 12.8 Macroeconomic Indicators

CHAPTER 13 Pharmaceuticals in the United Kingdom

• 13.1 Market Overview
• 13.2 Market Value
• 13.3 Market Segmentation I
• 13.4 Market Segmentation II
• 13.5 Market Share
• 13.6 Five Forces Analysis
• 13.7 Market Forecasts
• 13.8 Macroeconomic Indicators

CHAPTER 14 Pharmaceuticals in Asia-Pacific

• 14.1 Market Overview
• 14.2 Market Value
• 14.3 Market Segmentation I
• 14.4 Market Segmentation II
• 14.5 Market Share
• 14.6 Five Forces Analysis
• 14.7 Market Forecasts

CHAPTER 15 Pharmaceuticals in Europe

• 15.1 Market Overview
• 15.2 Market Value
• 15.3 Market Segmentation I
• 15.4 Market Segmentation II
• 15.5 Market Share
• 15.6 Five Forces Analysis
• 15.7 Market Forecasts
• 15.8 Macroeconomic Indicators

CHAPTER 16 COMPANY PROFILES

• 16.1 Leading Companies

CHAPTER 17 Appendix

• 17.1 Data Research Methodology
• 17.2 Report writing team

List of Tables

• Table 1: Global Pharmaceuticals Market Value: $ million, 2003-2007
• Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 4: Global Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 5: Global Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 6: Canada Pharmaceuticals Market Value: $ million, 2003-2007
• Table 7: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 8: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 9: Canada Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 10: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 11: Canada Size of Population (million) , 2003-2007
• Table 12: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 13: Canada Inflation, 2003-2007
• Table 14: Canada Exchange Rate, 2003-2007
• Table 15: United States Pharmaceuticals Market Value: $ million, 2003-2007
• Table 16: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 17: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 18: United States Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 19: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 20: United States Size of Population (million) , 2003-2007
• Table 21: United States GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 22: United States Inflation, 2003-2007
• Table 23: China Pharmaceuticals Market Value: $ million, 2003-2007
• Table 24: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 25: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 26: China Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 27: China Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 28: China Size of Population (million) , 2003-2007
• Table 29: China GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 30: China Inflation, 2003-2007
• Table 31: China Exchange Rate, 2003-2007
• Table 32: Japan Pharmaceuticals Market Value: $ million, 2003-2007
• Table 33: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 34: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 35: Japan Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 36: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 37: Japan Size of Population (million) , 2003-2007
• Table 38: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 39: Japan Exchange Rate, 2003-2007
• Table 40: Belgium Pharmaceuticals Market Value: $ million, 2003-2007
• Table 41: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 42: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 43: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 44: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 45: Belgium Size of Population (million) , 2003-2007
• Table 46: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 47: Belgium Inflation, 2003-2007
• Table 48: Belgium Exchange Rate, 2003-2007
• Table 49: France Pharmaceuticals Market Value: $ million, 2003-2007
• Table 50: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 51: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 52: France Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 53: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 54: France Size of Population (million) , 2003-2007
• Table 55: France GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 56: France Inflation, 2003-2007
• Table 57: France Exchange Rate, 2003-2007
• Table 58: Germany Pharmaceuticals Market Value: $ million, 2003-2007
• Table 59: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 60: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 61: Germany Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 62: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 63: Germany Size of Population (million) , 2003-2007
• Table 64: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 65: Germany Inflation, 2003-2007
• Table 66: Germany Exchange Rate, 2003-2007
• Table 67: Italy Pharmaceuticals Market Value: $ million, 2003-2007
• Table 68: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 69: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 70: Italy Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 71: Italy Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 72: Italy Size of Population (million) , 2003-2007
• Table 73: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 74: Italy Inflation, 2003-2007
• Table 75: Italy Exchange Rate, 2003
• Table 76: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007
• Table 77: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 78: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 79: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 80: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 81: Netherlands Size of Population (million) , 2003-2007
• Table 82: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 83: Netherlands Inflation, 2003-2007
• Table 84: Netherlands Exchange Rate, 2003-2007
• Table 85: Spain Pharmaceuticals Market Value: $ million, 2003-2007
• Table 86: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 87: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 88: Spain Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 89: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 90: Spain Size of Population (million) , 2003-2007
• Table 91: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 92: Spain Inflation, 2003-2007
• Table 93: Spain Exchange Rate, 2003-2007
• Table 94: United Kingdom Pharmaceuticals Market Value: $ million, 2003-2007
• Table 95: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 96: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 97: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 98: United Kingdom Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 99: United Kingdom Size of Population (million) , 2003-2007
• Table 100: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007
• Table 101: United Kingdom Inflation, 2003-2007
• Table 102: United Kingdom Exchange Rate, 2003-2007
• Table 103: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007
• Table 104: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 105: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 106: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 107: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 108: Europe Pharmaceuticals Market Value: $ million, 2003-2007
• Table 109: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
• Table 110: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
• Table 111: Europe Pharmaceuticals Market Share: % Share, by Value, 2007
• Table 112: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012
• Table 113: Europe Exchange Rate, 2003-2007
• Table 114: Key Facts: Pfizer Inc
• Table 115: Key Financials: Pfizer Inc
• Table 116: Key Facts: GlaxoSmithKline Plc